Literature DB >> 14743368

It's a double knock-out! The quaking mouse is a spontaneous deletion of parkin and parkin co-regulated gene (PACRG).

Paul J Lockhart1, Casey A O'Farrell, Matthew J Farrer.   

Abstract

Mutations in the parkin gene (PRKN) are the commonest cause of juvenile and early-onset parkinsonism. However, the pathogenic mechanism by which loss of parkin protein results in degeneration of dopaminergic neurons remains elusive. Animal models provide a useful tool for the study of development and disease, and the recent production of transgenic fly and mouse parkin deficient models allows investigation of the molecular role of parkin in dopamine regulation and nigrostriatal function. We have identified the mouse mutant Quaking as a spontaneously occurring PRKN knockout. The quaking mutation is a deletion of approximately 1.17 Mb of mouse chromosome 17, resulting in the deletion of the entire promoter and first five coding exons of PRKN In addition, the recently described Parkin Co-Regulated Gene (PACRG) is completely deleted. Homozygous Quaking mice show a complete loss of PRKN and PACRG mRNA and protein. These mice will constitute a useful additional model for studies of the molecular role of parkin and PACRG in neurodegeneration. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14743368     DOI: 10.1002/mds.20000

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

Review 1.  Parkinson's disease: a rethink of rodent models.

Authors:  Heather L Melrose; Sarah J Lincoln; Glenn M Tyndall; Matthew J Farrer
Journal:  Exp Brain Res       Date:  2006-04-26       Impact factor: 1.972

2.  Parkin-deficient mice are not a robust model of parkinsonism.

Authors:  Francisco A Perez; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

Review 3.  Genetic mouse models of parkinsonism: strengths and limitations.

Authors:  Sheila M Fleming; Pierre-Olivier Fernagut; Marie-Françoise Chesselet
Journal:  NeuroRx       Date:  2005-07

4.  A quantitative survey of gravity receptor function in mutant mouse strains.

Authors:  Sherri M Jones; Kenneth R Johnson; Heping Yu; Lawrence C Erway; Kumar N Alagramam; Natasha Pollak; Timothy A Jones
Journal:  J Assoc Res Otolaryngol       Date:  2005-12

5.  Deletion of the Parkin coregulated gene causes male sterility in the quaking(viable) mouse mutant.

Authors:  Diego Lorenzetti; Colin E Bishop; Monica J Justice
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

6.  Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.

Authors:  Xiao-Hong Lu; Sheila M Fleming; Bernhard Meurers; Larry C Ackerson; Farzad Mortazavi; Victor Lo; Daniela Hernandez; David Sulzer; George R Jackson; Nigel T Maidment; Marie-Francoise Chesselet; X William Yang
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

Review 7.  Model fusion, the next phase in developing animal models for Parkinson's disease.

Authors:  Amy B Manning-Bog; J William Langston
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

8.  MEIG1 is essential for spermiogenesis in mice.

Authors:  Zhibing Zhang; Xuening Shen; David R Gude; Bonney M Wilkinson; Monica J Justice; Charles J Flickinger; John C Herr; Edward M Eddy; Jerome F Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

9.  Loss of p53 in quaking viable mice leads to Purkinje cell defects and reduced survival.

Authors:  Christina Gavino; Stéphane Richard
Journal:  Sci Rep       Date:  2011-09-06       Impact factor: 4.379

Review 10.  Ubiquitin domain proteins in disease.

Authors:  Louise Madsen; Andrea Schulze; Michael Seeger; Rasmus Hartmann-Petersen
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.